Literature DB >> 3282147

Dynamics of the protein metabolic response to burn injury.

F Jahoor1, M Desai, D N Herndon, R R Wolfe.   

Abstract

The protein metabolic response to burn injury was assessed in 17 children aged 7.1 +/- 1.1 years (mean +/- SEM) and a mean burn size of 65 +/- 7% total body surface area (TBSA) during the acute, flow, convalescent, and recovery phases. Stable isotopes of leucine, valine, lysine, and urea were infused in postabsorptive patients in order to measure protein kinetics. The absolute rate of protein breakdown was assessed from the plasma flux of the essential amino acids (EAA), and the rate of urea production (Ra urea) was used as an index of net protein catabolism. Compared to values obtained in recovered patients, the plasma fluxes of all three EAAs were significantly increased (P less than .05), indicating an increased protein breakdown, during the acute, flow, and convalescent phases of injury. Ra urea, however, was only significantly increased during the flow phase (P less than .01), suggesting that protein breakdown was adequately counteracted in the acute and convalescent phases by elevations in protein synthesis but not in the flow phase. The protein kinetic response did not correlate with changes in the metabolic rate since resting energy expenditure (REE) was significantly increased above predicted levels during the acute and flow phases (by 40% and 50%, respectively), and returned to normal in convalescence.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3282147     DOI: 10.1016/0026-0495(88)90132-1

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  28 in total

1.  Satellite cell activation and apoptosis in skeletal muscle from severely burned children.

Authors:  Christopher S Fry; Craig Porter; Labros S Sidossis; Christopher Nieten; Paul T Reidy; Gabriel Hundeshagen; Ronald Mlcak; Blake B Rasmussen; Jong O Lee; Oscar E Suman; David N Herndon; Celeste C Finnerty
Journal:  J Physiol       Date:  2016-07-15       Impact factor: 5.182

2.  Stimulation of muscle protein synthesis by long-term insulin infusion in severely burned patients.

Authors:  Y Sakurai; A Aarsland; D N Herndon; D L Chinkes; E Pierre; T T Nguyen; B W Patterson; R R Wolfe
Journal:  Ann Surg       Date:  1995-09       Impact factor: 12.969

3. 

Authors:  F Ravat; R Le Floch
Journal:  Ann Burns Fire Disasters       Date:  2015-12-31

Review 4.  Diabetes mellitus and burns. Part I-basic science and implications for management.

Authors:  Ioannis Goutos; Rebecca Spenser Nicholas; Atisha A Pandya; Sudip J Ghosh
Journal:  Int J Burns Trauma       Date:  2015-03-20

Review 5.  Current problems in burn hypermetabolism.

Authors:  Christian Sommerhalder; Elizabeth Blears; Andrew J Murton; Craig Porter; Celeste Finnerty; David N Herndon
Journal:  Curr Probl Surg       Date:  2019-11-11       Impact factor: 1.909

6.  Whole body and skeletal muscle protein turnover in recovery from burns.

Authors:  Craig Porter; Nicholas M Hurren; David N Herndon; Elisabet Børsheim
Journal:  Int J Burns Trauma       Date:  2013-01-24

7.  Acute dichloroacetate administration increases skeletal muscle free glutamine concentrations after burn injury.

Authors:  A A Ferrando; D L Chinkes; S E Wolf; S Matin; D N Herndon; R R Wolfe
Journal:  Ann Surg       Date:  1998-08       Impact factor: 12.969

Review 8.  Metabolic implications of severe burn injuries and their management: a systematic review of the literature.

Authors:  Bishara S Atiyeh; S William A Gunn; Saad A Dibo
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

Review 9.  The hepatic response to thermal injury: is the liver important for postburn outcomes?

Authors:  Marc G Jeschke
Journal:  Mol Med       Date:  2009-04-10       Impact factor: 6.354

Review 10.  Insulin resistance postburn: underlying mechanisms and current therapeutic strategies.

Authors:  Gerd G Gauglitz; David N Herndon; Marc G Jeschke
Journal:  J Burn Care Res       Date:  2008 Sep-Oct       Impact factor: 1.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.